|
WNK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.47019984864505E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.54330001503433E-10 |
| Normal-vs-Stage2 |
3.85219967036221E-10 |
| Normal-vs-Stage3 |
8.53500048414446E-10 |
| Normal-vs-Stage4 |
6.25049999536387E-08 |
| Stage1-vs-Stage2 |
5.491400E-01 |
| Stage1-vs-Stage3 |
2.435400E-01 |
| Stage1-vs-Stage4 |
6.696400E-01 |
| Stage2-vs-Stage3 |
5.246200E-01 |
| Stage2-vs-Stage4 |
9.225000E-01 |
| Stage3-vs-Stage4 |
7.652600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.46790041128031E-10 |
| Normal-vs-AfricanAmerican |
1.53290002913309E-09 |
| Normal-vs-Asian |
8.97800001009585E-09 |
| Caucasian-vs-AfricanAmerican |
1.064850E-01 |
| Caucasian-vs-Asian |
7.499800E-01 |
| AfricanAmerican-vs-Asian |
7.692600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.51350051883037E-10 |
| Normal-vs-Female |
4.79799999730801E-09 |
| Male-vs-Female |
3.498000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.02390010201259E-10 |
| Normal-vs-Extreme_Weight |
7.48120454474588E-11 |
| Normal-vs-Obese |
1.19929999264912E-09 |
| Normal-vs-Extreme_Obese |
5.90599999999997E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.364400E-02 |
| Normal_Weight-vs-Obese |
4.859600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.102200E-01 |
| Extreme_Weight-vs-Obese |
4.583300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.176000E-01 |
| Obese-vs-Extreme_Obese |
8.899400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.13919999492163E-08 |
| Normal-vs-Age(41-60Yrs) |
7.27150006873956E-10 |
| Normal-vs-Age(61-80Yrs) |
2.43180031667123E-10 |
| Normal-vs-Age(81-100Yrs) |
4.9858006612169E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.303800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.937600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.784700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.281600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.704100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.014630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.77470038664751E-10 |
| Normal-VS-Type2 PRCC |
3.2078995015894E-10 |
| Normal-VS-KIRP CIMP |
2.04440000000083E-05 |
| Normal-VS-Unclassified PRCC |
2.31550001394965E-09 |
| Type1 PRCC-VS-Type2 PRCC |
4.071400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.737540E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.334400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.822800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.271800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.226400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.55719906256036E-11 |
| Normal-vs-N1 |
1.99010000001554E-06 |
| Normal-vs-N2 |
1.456500E-02 |
| N0-vs-N1 |
2.484500E-02 |
| N0-vs-N2 |
1.394220E-02 |
| N1-vs-N2 |
9.350400E-01 |
|
|
